Abstract:Background: Pain is a complex perception involving unpleasant somatosensory and emotional experiences. However, the underlying mechanisms that mediate its different components remain unclear. Sphingosine-1-phosphate (S1P), a metabolite of sphingomyelin and a potent lipid mediator, initiates signaling via G protein-coupled receptors (S1PRs) on cell surfaces. It serves as a second messenger in cellular processes such as proliferation and apoptosis. Nevertheless, the neuropharmacology of sphingolipid signaling in pain conditions within the central nervous system remains largely unexplored and controversial. Methods: Chronic nociceptive pain models were induced in vivo by intraplantar injection of 20 μL complete Freund's adjuvant (CFA) into the left hind paws. We assessed S1P and S1PR1 expression in the spinal cords of CFA model mice. Functional antagonists of S1PR1 or S1PR1-specific siRNA were administered daily following CFA model establishment. Paw withdrawal response frequency (PWF) and paw withdrawal latency (PWL) were measured to evaluate mechanical allodynia and thermal hyperalgesia, respectively. RT-PCR assessed interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α levels. Western blotting and immunofluorescence were used to analyze glial fibrillary acidic protein (GFAP), ionized calcium-binding adapter molecule (Iba1), STAT3, ERK, and p38 MAPK protein expression. Results: In the chronic nociceptive pain model induced by CFA, S1P and S1PR1 expression levels were significantly elevated, leading to activation of spinal cord glial cells. S1PR1 activation also promoted MMP2-mediated cleavage of mature IL-1β. Additionally, S1PR1 activation upregulated phosphorylation of STAT3, ERK, and p38 MAPK in glial cells, profoundly impacting downstream signaling pathways and contributing to chronic nociceptive pain. Conclusion: The S1P/S1PR1 axis plays a pivotal role in the cellular and molecular mechanisms underlying nociceptive pain. This signaling pathway modulates glial cell activation and the expression of pain-related genes (STAT3, ERK, p38 MAPK) and inflammatory factors in the spinal dorsal horn. These findings underscore the potential of targeting the S1P system for developing novel analgesic therapies.

S1P/S1PRs-TRPV4 Axis is a Novel Therapeutic Target for Persistent Pain and Itch in Chronic Dermatitis

Sensory TRP channels contribute differentially to skin inflammation and persistent itch

20-HETE mediated TRPV1 activation drives allokinesis via MrgprA3 + neurons in chronic dermatitis

S1P/S1PR1 signaling is involved in the development of nociceptive pain

Differential contribution of sensory transient receptor potential channels in response to the bioactive lipid sphingosine-1-phosphate

Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch.

S1P-S1PRs Alliance in Neuropathic Pain Processing

Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch

Inflammatory mediators causing cutaneous chronic itch in some diseases via transient receptor potential channel subfamily V member 1 and subfamily A member 1

TRPV4-β-catenin axis is a novel therapeutic target for dry skin-induced chronic itch

Vascular Endothelial Growth Factor a Promotes Chronic Itch via VEGFA-VEGFR2-PI3K-TRPV1 Axis in Allergic Contact Dermatitis

Mechanisms of the PD-1/PD-L1 pathway in itch: From acute itch model establishment to the role in chronic itch in mouse

New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms?

Sensory neuron–expressed TRPC3 mediates acute and chronic itch

Altered Expression of Itch‑related Mediators in the Lower Cervical Spinal Cord in Mouse Models of Two Types of Chronic Itch.

Common and discrete mechanisms underlying chronic pain and itch: peripheral and central sensitization

Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice

CYP1B1-derived epoxides modulate the TRPA1 channel in chronic pain

CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis

Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics

Mechanical and chemical itch regulated by neuropeptide Y-Y1 signaling